You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

UGT1A1*28

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Kaohsiung (UGT1A1 genotyping (6,6), UGTIA1 genotyping (6,7), UGTIA1 genotyping (7,7))

Completed
  • Metastatic Colorectal Cancer
  • UGT1A1 genotyping (6,6)
  • +7 more
  • Kaohsiung, Taiwan
    Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Nov 9, 2021

Solid Tumors, Hematological Malignancies Trial in Santa Monica, Whittier, Canton (Belinostat IV)

Completed
  • Solid Tumors
  • Hematological Malignancies
  • Belinostat IV
  • Santa Monica, California
  • +2 more
Sep 10, 2021

UGT1A1 Genotyping in Taiwanese Cancer Patients

Not yet recruiting
  • The Influence of the UGT1A1 Genotype
    • (no location specified)
    Mar 20, 2023

    Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Low Dose OXIRI (LD-OXIRI)
    • Singapore, Singapore
      National Cancer Centre, Singapore
    Jun 29, 2023

    Colorectal Cancer Trial in France (bevacizumab, fluorouracil, irinotecan HCl)

    Completed
    • Colorectal Cancer
    • bevacizumab
    • +3 more
    • Abbeville, France
    • +31 more
    Nov 5, 2020

    Rectal Cancer Stage III Trial in Hangzhou (Neoadjuvant chemoradiotherapy based on irinotecan)

    Recruiting
    • Rectal Cancer Stage III
    • Neoadjuvant chemoradiotherapy based on irinotecan
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Dec 7, 2021

    Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)

    Completed
    • Immune System Disorder (Healthy Volunteers)
    • Miami, Florida
      Investigational Site Number: 8400001
    Apr 11, 2023

    Colorectal Cancer Trial (bevacizumab, filgrastim, fluorouracil)

    Completed
    • Colorectal Cancer
    • bevacizumab
    • +4 more
    • (no location specified)
    Mar 27, 2020

    Cancer Trial in Ann Arbor (DPYD or UGT1A1 variants)

    Not yet recruiting
    • Cancer
    • DPYD or UGT1A1 variants
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Dec 20, 2022

    (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of

    Recruiting
    • Colorectal Neoplasms
      • Maastricht, Limburg, Netherlands
        Maastricht UMC+
      Jan 10, 2023

      Primary Mitochondrial Disease Trial in Germany, Italy (OMT-28)

      Recruiting
      • Primary Mitochondrial Disease
      • Bonn, Germany
      • +5 more
      Aug 3, 2023

      Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics

      Recruiting
      • Gastrointestinal Cancer
      • +4 more
      • Availability of clinical decision support based on pharmacogenomic results.
      • Chicago, Illinois
        University of Chicago Medical Center
      Oct 20, 2022

      Acute Aortic Syndrome, Aortic Dissectio Trial in Nanjing, Beijing (Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic

      Recruiting
      • Acute Aortic Syndrome
      • Aortic Dissectio
      • Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic Acid-28D-L-Alanine-28E-L-Proline-28F-L-Alanine-28G-L-Asparagine-
      • Blank control
      • Nanjing, Jiangsu, China
      • +2 more
      Sep 25, 2022

      Pharmacogenomics Trial (Indapamide 1.5 MG SR)

      Not yet recruiting
      • Pharmacogenomics
      • Indapamide 1.5 MG SR
      • (no location specified)
      Mar 15, 2022

      Diabetes Trial in Gières (Sotagliflozin (SAR439954), Mefenamic acid)

      Completed
      • Diabetes Mellitus
      • Sotagliflozin (SAR439954)
      • Mefenamic acid
      • Gières, France
        Investigational site 250001
      Apr 21, 2022

      B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

      Recruiting
      • B-Cell Lymphoma
      • +4 more
      • 19(T2)28z1xx TRAC T cell
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Feb 24, 2023

      Acute Myeloid Leukemia Trial in Valencia (AFM28)

      Recruiting
      • Acute Myeloid Leukemia
      • Valencia, Spain
        Hospital Universitari i Politècnic La Fe
      Apr 5, 2023

      Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)

      Recruiting
      • Cystic Fibrosis
      • ABCI
      • Placebo
      • Christchurch, New Zealand
        New Zealand Clinical Research
      Apr 4, 2023

      Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

      Not yet recruiting
      • Advanced Prostate Cancer
      • Lyon, France
      • +2 more
      Oct 18, 2023

      Metabolic Syndrome Trial in Québec (INV-202, Placebo)

      Completed
      • Metabolic Syndrome
      • Québec, Quebec, Canada
        Syneos Health Clinique Inc
      Oct 3, 2022

      Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

      Not yet recruiting
      • Marginal Zone Lymphoma
      • Mosunetuzumab + Lenalidomide
      • +3 more
      • (no location specified)
      Aug 16, 2023

      Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)

      Not yet recruiting
      • Pancreatic Cancer
      • Nanjing, Jiangsu, China
        The Affiliated Hospital of Nanjing University Medical School
      Nov 21, 2023

      Esophageal Squamous Cell Carcinoma Abdominal Stage 0 Trial in Guangzhou (PD-1 Inhibitors, Irinotecan, Capecitabine tablets)

      Recruiting
      • Esophageal Squamous Cell Carcinoma Abdominal Stage 0
      • PD-1 Inhibitors
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Feb 20, 2023

      Healthy Volunteers Trial in Adelaide (Epetraborole, Placebo)

      Completed
      • Healthy Volunteers
      • Adelaide, South Australia, Australia
        CMAX Clinical Research
      Mar 1, 2022

      Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

      Not yet recruiting
      • Breast Neoplasms
      • Guangzhou, Gangdong, China
        Sun-yat sen university cancer center
      Jul 30, 2023